Dominik Mumberg
Ascendis Pharma (Denmark)(DK)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Cancer-related Molecular Pathways, Prostate Cancer Treatment and Research, Microtubule and mitosis dynamics, Cancer Mechanisms and Therapy
Most-Cited Works
- → Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds(1995)1,990 cited
- → Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression(1994)973 cited
- → CD4+T cells eliminate MHC class II-negative cancer cellsin vivoby indirect effects of IFN-γ(1999)380 cited
- → BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models(2013)254 cited
- → The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models(2019)203 cited
- → Use of the Novel Plk1 Inhibitor ZK-Thiazolidinone to Elucidate Functions of Plk1 in Early and Late Stages of Mitosis(2007)198 cited